Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

37 ! Sun, 7/29/2018, 2:00 PM - 3:50 PM CC-West 304/305
Statistical Issues Specific the Therapeutic Areas - 1 — Contributed Papers
Biopharmaceutical Section
Chair(s): Hui Wang, Amgen, Inc.
2:05 PM Robust Dose Response Estimation

Shouhao Zhou, University of Texas MD Anderson Cancer Center
2:20 PM Statistical Development in Addressing Delayed Treatment Effect or Crossing Survival Curves in Immuno-Oncology Clinical Trials

Huyuan Yang, Takeda Oncology Pharmaceutical
2:35 PM Cure Survival Data in Oncology Studies

Shih-Yuan Lee, Takeda
2:50 PM Meta-Analysis for the Adjuvant Treatment in Renal Cell Carcinoma

Weichao Bao, Novartis Pharmaceuticals Corporation
3:05 PM Correlation Between the Time-To-Event Endpoints in Prostate Cancer Clinical Trials
Susan Li, Janssen R&D
3:20 PM Statistical Evaluation of Oncology Drug Trial Portfolios and the Potential for Inappropriate Regulatory Approval: a Simulation Study

Renee Gennarelli, Memorial Sloan Kettering Cancer Center; Peter Bach, Memorial Sloan Kettering Cancer Center; Mithat Gonen, Memorial Sloan Kettering Cancer Center
3:35 PM A Case Study on Model Based Meta-Analysis (MBMA) for Drug Development Decisions

Guohui Liu, Takeda Pharmaceuticals Inc ; Zhaoyang Teng, Takeda pharmaceuticals international, Co; Zhaowei Hua, Takeda Pharmaceuticals International Co.; Neeraj Gupta, Takeda pharmaceuticals international, Co; Richard Labotka, Takeda pharmaceuticals international, Co